VIGL (Vigil Neuroscience) Year-over-year net earnings per share growth for the last 12 months
Vigil Neuroscience brings together leading neuroimmunologists to target microglia therapy and combat rare pathologies. The quarterly change in earnings per share confirms this potential, with the -6.90 mark reflecting the current state of the metric. A stable scientific team and targeted managerial hiring strengthen the company's position, while a virtual manufacturing model utilizing external CMO sites optimizes the production of drug substances.
VIGL (Vigil Neuroscience, Inc.): analytical breakdowns and indicator data
- market value and analyst target forecast:
- business market valuation indicators:
- book capitalization indicators:
- business debt structure and liquidity details:
- earnings and market multiples details:
VIGL - Net Income|Projected Future Earnings Vigil Neuroscience|VIGL - Business Payback Period|Forward P/E Multiple vigilneuro.com|VIGL - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vigil Neuroscience Inc.|VIGL - Operating profit before amortization|Net earnings per share (EPS TTM) Vigil Neuroscience|VIGL - Net earnings per share for the last 12 months|Quarterly EPS earnings growth vigilneuro.com|VIGL - Earnings per share growth rate in current year|Expected earnings per share growth for next year Vigil Neuroscience
- company sales and revenue statistics:
Summary company analytics:Vigil Neuroscience
When constructing a long-term portfolio, it is critical to filter out overvalued assets by analyzing net profit per share dynamics. This quarterly EPS growth performance metric measures the rate of change in profitability, which for Vigil Neuroscience (VIGL), possessing the potential for pricing power in microglia therapy, allows for the identification of the transition point from the investment phase to the actual monetization of unique developments.
Analysis of competing companies
BIIB: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Bioscience Ltd) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Axsome Therapeutics, Inc. AXSM|Year-over-year net earnings per share growth for the last 12 months ACAD (ACADIA Pharmaceuticals Inc.)|XENE: Year-over-year net earnings per share trend for the last twelve months|Viking Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Supernus Pharmaceuticals (SUPN)|CPRX: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months DNLI (Denali Therapeutics)|HRMY: Quarterly EPS earnings growth|BHVN (Biohaven Pharmaceutical) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months Amylyx|Quarterly EPS earnings growth Trevi Corp|Quarterly EPS earnings growth PRAX|AVXL (anavex.com) - Year-over-year earnings per one share growth for the last 12 months|CeriBell Inc - Year-over-year net earnings per share growth for the last 12 months|PRTA (Prothena Corporation plc) - Year-over-year net earnings per share trend for the last twelve months|ALEC - Year-over-year earnings per share growth for the last twelve months|ANNX (Annexon Biosciences Inc.) - Year-over-year earnings per share growth for the last 12 months|OMER (omeros.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last 12 months NGNE|Year-over-year net earnings per share growth for the last 12 months ACIU|Quarterly EPS earnings growth Voyager Pharma|Year-over-year net earnings per share growth for the last 12 months NMRA (Neumora Therapeutics, Inc.)|SCLX - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tevogen Bio TVGN|Alpha Cognition Corp (ACOG) - Earnings per share growth in annualized terms for the last twelve months|CGTX: Year-over-year net earnings per share growth for the last 12 months|Inhibikase Therapeutics, Inc. - Year-over-year earnings per share growth rate for the last twelve months|SAVA: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months ASRT|COYA (coyatherapeutics.com) - Quarterly EPS earnings growth|Vistagen (VTGN) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OVID (Ovid Rx)|Year-over-year net earnings per share change for the last twelve months Acumen Pharmaceuticals, Inc.|Quarterly EPS earnings growth CRVO (CervoMed Corporation)|Year-over-year earnings per share growth rate for the last twelve months ATHE (Alterity Therapeutics Ltd)|Clene Nanomedicine - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year pepgen.com (PEPG)|JUNS: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RLMD|ANVS (Annovis Bio Inc) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Grace Therapeutics, Inc. (GRCE)|Quarterly EPS earnings growth AIFF|Year-over-year earnings per share growth rate for the last twelve months KLTO|Year-over-year earnings per share growth for the last twelve months neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Earnings per share growth in annualized terms for the last twelve months|MetaVia Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months NeurAxis Inc NRXS|HSDT (Helius Medical Technologies Inc.) - Year-over-year net earnings per share growth for the last 12 months|Passage Bio Inc. (PASG) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Neuphoria|Year-over-year net earnings per share growth for the last 12 months Minerva Neurosciences, Inc. (NERV)|Year-over-year earnings per share growth for the last twelve months Athira (ATHA)|Addex Therapeutics - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Alzamend Neuro, Inc. ALZN|Cyclerion (CYCN) - Earnings per share growth in annualized terms for the last twelve months|PTIX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Pasithea Therapeutics Corp KTTA|Cortigent, Inc. (CRGT) - Year-over-year earnings per share growth for the last twelve months|Avenue Therapeutics - Year-over-year earnings per one share growth for the last 12 months|BCLI (brainstorm-cell.com) - Quarterly EPS earnings growth|CARA: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share growth for the trailing year Longboard Pharma|MRNS - Year-over-year earnings per share growth for the last twelve months|NKGen Biotech, Inc. (NKGN) - Year-over-year net earnings per share growth for the last 12 months|NRBO (NeuroBo Pharmaceuticals, Inc.) - Year-over-year net earnings per share growth for the last 12 months|Sage Therapeutics - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Synaptogenix, Inc.|TRVN: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WENA|Quarterly EPS earnings growth cerevel.com (CERE)
